Skip to content
TrackPodcasts
healthJul 24, 202352:03pending

18: Could This Simple Blood Test Revolutionize Early Cancer Detection?

About this episode

Buck talks with GRAIL President Josh Ofman, MD, MSHS, about their groundbreaking Multi-cancer early detection (MCED) technology and it's promise as a significant new tool in the war on cancer.

  • 0:00:00 - Advancements in Cancer Detection Technology
  • 0:00:35 - GRAIL Galleri test
  • 0:02:11 - About Dr. Josh Ofman
  • 0:05:14 - Cancer really is a disease of the genome
  • 0:12:35 - Various guidelines for early detection of certain cancers
  • 0:16:45 - Cancer Detection in Blood Biology
  • 0:19:03 - Cell-Free DNA
  • 0:23:38 - How many cancers is the GRAIL Galleri test able to detect? 
  • 0:27:10 - How accurate is the GRAIL Galleri test?
  • 0:31:49 - Limitations of the GRAIL Galleri test
  • 0:36:18 - Why would oncologists be against this test?
  • 0:40:57 - What happens after one gets a a "cancer signal detected" result?
  • 0:45:13 - GRAIL Galleri test's Impact on Cancer Screening
  • 0:48:42 - The cost of the GRAIL Galleri test

Get every episode summarized

Each time Longevity Roadmap publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

18: Could This Simple Blood Test Revolutionize Early Cancer Detection?

Longevity Roadmap

0:00
52:03

More episodes

More from Longevity Roadmap

View all episodes →